$10k of savings? I'd buy these ASX 200 shares to grow my money

MotleyFool03-12

If you have $10,000 to invest right now, there are some excellent S&P/ASX 200 Index (ASX: XJO) stocks that can grow that money. When choosing stocks, I take the view of whether that cash will be ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2418438367?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-03-12 00:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2418438367","market":"hk","top_or_hot":-1,"title":"$10k of savings? I'd buy these ASX 200 shares to grow my money","media":"MotleyFool","content":"<div>\n<p>If you have $10,000 to invest right now, there are some excellent S&P/ASX 200 Index (ASX: XJO) stocks that can grow that money. When choosing stocks, I take the view of whether that cash will be ...</p>\n\n<a href=\"https://www.fool.com.au/2024/03/12/10k-of-savings-id-buy-these-asx-200-shares-to-grow-my-money/\">Source Link</a>\n\n</div>\n","source":"motleyfoolau_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>$10k of savings? I'd buy these ASX 200 shares to grow my money</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n$10k of savings? I'd buy these ASX 200 shares to grow my money\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-03-12 00:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com.au/2024/03/12/10k-of-savings-id-buy-these-asx-200-shares-to-grow-my-money/><strong>MotleyFool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>If you have $10,000 to invest right now, there are some excellent S&P/ASX 200 Index (ASX: XJO) stocks that can grow that money. When choosing stocks, I take the view of whether that cash will be ...</p>\n\n<a href=\"https://www.fool.com.au/2024/03/12/10k-of-savings-id-buy-these-asx-200-shares-to-grow-my-money/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NEU.AU","symbol_name":"NEUREN PHARMACEUTICALS LTD","start_time":0,"source_url":"https://www.fool.com.au/2024/03/12/10k-of-savings-id-buy-these-asx-200-shares-to-grow-my-money/","article_id":"2418438367","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2418438367","pubTimestamp":1710172800,"sourceInfo":{"source_id":"motleyfoolau_stock","name":"MotleyFool"},"weMediaInfo":null,"summary":"If you have $10,000 to invest right now, there are some excellent S&P/ASX 200 Index (ASX: XJO) stocks that can grow that money. When choosing stocks, I take the view of whether that cash will be inves","collect":0,"end_time":0,"defaultTopTitle":"fool.com.au","property":[],"viewcount":null,"language":"en","relate_stocks":{"NEU.AU":"NEUREN PHARMACEUTICALS LTD","BK7503":"科技股","BK7096":"制药","LU2065169927.USD":"M&G (LUX) GLOBAL MAXIMA \"A\" (USD) ACC","BK7508":"医药生物股","LU2065171311.SGD":"M&G (LUX) GLOBAL MAXIMA \"A\" (SGD) ACC","BK7016":"应用软件","BK4139":"生物科技","XRO.AU":"XERO LTD","LU2065170008.USD":"M&G (LUX) GLOBAL MAXIMA \"A\" (USD) INC","LU2065171402.SGD":"M&G (LUX) GLOBAL MAXIMA \"A\" (SGD) INC","XJO.AU":"标普/澳交所 200指数","ACAD":"阿卡迪亚"},"translate_title":"1万美元的储蓄？我会买这些ASX 200股票来增加我的钱","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ACAD":1,"NEU.AU":1,"XJO.AU":1,"XRO.AU":1},"content_text":"If you have $10,000 to invest right now, there are some excellent S&P/ASX 200 Index (ASX: XJO) stocks that can grow that money. When choosing stocks, I take the view of whether that cash will be invested in companies that will be doing better in 2029 than right now. Here are two I reckon that are looking pretty damn good at the moment: Pivoting from cash burner to cash saver Xero Ltd (ASX: XRO) is an old favourite, but it's a company that continues to adapt well to changing conditions. The market has very much appreciated the change in direction that chief executive Sukhinder Singh Cassidy has brought over her 13-month tenure. She has transformed the mindset of the software business from a grow-at-all-costs startup attitude to a more mature controlled-growth strategy. Costs have been cut in an attempt to increase cash flow and margins.  The Xero share price has thus rocketed 70% over the past 12 months. Singh Cassidy's work is far from done yet though, so I feel like this is one to buy as a long-term investment. The chances that the New Zealand tech company will be in better shape in five years' time compared to now seems reasonably high. The ASX 200 shares under attack In contrast, Neuren Pharmaceuticals Ltd (ASX: NEU) hasn't started 2024 in the best way. The ASX 200 biotech shares are now 20% lower than where they started the year. A short seller report has had much to do with investors fleeing this Australian company, which develops treatments for rare neurological disorders.  Neuren has a business model where its already commercially approved drug, Daybue, is licenced out to US giant Acadia Pharmaceuticals Inc (NASDAQ: ACAD) for sale to the public. This brings in revenue for Neuren, which it uses to fund its pipeline of drugs under development and testing. Last month, US short seller Culper Research did not target Neuren specifically but accused Acadia of understating the side effects of Daybue. However, fund managers are sticking by the embattled ASX 200 share. While some have reduced their share price predictions, all six analysts currently surveyed on CMC Invest are still rating Neuren as a buy. Again, with several products under development, the chance that this company will be bigger and better in five years seems pretty decent.","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2418438367"}